Intellia Therapeutics Announces Second Quarter 2017 Financial Results – GlobeNewswire (press release)
MoneyMakingArticles |
Intellia Therapeutics Announces Second Quarter 2017 Financial Results
GlobeNewswire (press release) CAMBRIDGE, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, announced financial and … EPS for Chimerix (CMRX) Expected At $-0.41; Intellia Therapeutics (NTLA) Shorts Increased By 11.26% Intellia Therapeutics Inc. – Receive News & Ratings Daily |
